Richard D. Kim, Aidan Manning, Nicole Zhang, Keelia Clemens. "First-line GemCis ± immunotherapy vs FGFR inhibition in ctDNA-detected
                    <i>FGFR2</i>
                    fusion–positive advanced cholangiocarcinoma: A real-world analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.4159